Browsing by Contributors Gelber, Richard D

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
آ ب پ ت ث ج چ ح خ د ذ ر ز ژ س ش ص ض ط ظ ع غ ف ق ک گ ل م ن و ه ی
 
Showing results 1 to 14 of 14
PreviewIssue DateTitleContributor(s)
2016 JCO Volume 34 Issue 19 July (15).pdf.jpg2016Absolute Bene fi t of Adjuvant Endocrine Therapies for Premenopausal Women With Hormone Receptor – Positive , Human Epidermal Growth Factor Receptor 2 – Negative Early Breast Cancer : TEXT and SOFT TrialsRegan, Meredith M; Francis, Prudence A; Pagani, Olivia; Fleming, Gini F; Walley, Barbara A; Viale, Giuseppe; Colleoni, Marco; Tondini, Carlo; Pinotti, Graziella; Price, Karen N; Coates, Alan S; Goldhirsch, Aron; Gelber, Richard D
436.pdf.jpg29-Jan-2015Adjuvant ovarian suppression in premenopausal breast cancerFrancis, Prudence A; Regan, Meredith M; Fleming, Gini F; Láng, István; Ciruelos, Eva; Bellet, Meritxell; Bonnefoi, Hervé R; Climent, Miguel A; Da Prada, Gian Antonio; Burstein, Harold J; Martino, Silvana; Davidson, Nancy E; Geyer, Charles E; Walley, Barbara A; Coleman, Robert; Kerbrat, Pierre; Buchholz, Stefan; Ingle, James N; Winer, Eric P; Rabaglio-Poretti, Manuela; Maibach, Rudolf; Ruepp, Barbara; Giobbie-Hurder, Anita; Price, Karen N; Colleoni, Marco; Viale, Giuseppe; Coates, Alan S; Goldhirsch, Aron; Gelber, Richard D
2017 NEJM Volume 377 Issue 2 July (6).pdf.jpg2017Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast CancerZardavas, Dimitrios; Benyunes, Mark; Viale, Giuseppe; Suter, Thomas; Arahmani, Amal; Rouchet, Nathalie; Sc, M; Clark, Emma; Sc, M; Knott, Adam; Lang, Istvan; Levy, Christelle; Yardley, Denise A; Bines, Jose; Gelber, Richard D; Piccart, Martine; Baselga,
2016 JCO Volume 34 Issue 9 March (7).pdf.jpg2016Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up : Results From the International Breast Cancer Study Group Trials I to VColleoni, Marco; Sun, Zhuoxin; Price, Karen N; Karlsson, Per; Forbes, John F; Th, Beat; Gianni, Lorenzo; Castiglione, Monica; Gelber, Richard D; Coates, Alan S; Goldhirsch, Aron
Lancet 2017 Volume 389 Issue 10075 March (5).pdf.jpg2017Articles 11 years ’ follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer : final analysis of the HERceptin Adjuvant ( HERA ) trialCameron, David; Piccart-gebhart, Martine J; Gelber, Richard D; Procter, Marion; Goldhirsch, Aron; Azambuja, Evandro De; Jr, Gilberto Castro; Untch, Michael; Smith, Ian; Gianni, Luca; Baselga, Jose; Al-sakaff, Nedal; Lauer, Sabine; Mcfadden, Eleanor; Leyland-jones, Bria
2017 BJSmedicine Volume 51 Issue 17 September (12).pdf.jpg2017Designing Clinical Trials That Accept New Arms : An Example in Metastatic Breast CancerVentz, Steffen; Alexander, Brian M; Parmigiani, Giovanni; Gelber, Richard D; Trippa, Lorenzo
2017 JoCO Volume 35 Issue 27 September (12).pdf.jpg2017Designing Clinical Trials That Accept New Arms : An Example in Metastatic Breast CancerVentz, Steffen; Alexander, Brian M; Parmigiani, Giovanni; Gelber, Richard D; Trippa, Lorenzo
2018 JoCO Volume 36 Issue 11 April (11).pdf.jpg2018Ef fi cacy of Chemotherapy for ER-Negative and ER-Positive Isolated Locoregional Recurrence of Breast Cancer : Final Analysis of the CALOR TrialWapnir, Irene L; Price, Karen N; Anderson, Stewart J; Mart, Miguel; Nortier, Johan W R; Paterson, Alexander H G; Rimawi, Mothaffar F; Mamounas, Eleftherios P; Jr, Charles E Geyer; Gelber, Shari; Coates, Alan S; Gelber, Richard D; Rastogi, Priya
923.pdf.jpg5-Mar-2015Goserelin for ovarian protection during breast-cancer adjuvant chemotherapyMoore, Halle C F; Unger, Joseph M; Phillips, Kelly-Anne; Boyle, Frances; Hitre, Erika; Porter, David; Francis, Prudence A; Goldstein, Lori J; Gomez, Henry L; Vallejos, Carlos S; Partridge, Ann H; Dakhil, Shaker R; Garcia, Agustin A; Gralow, Julie; Lombard, Janine M; Forbes, John F; Martino, Silvana; Barlow, William E; Fabian, Carol J; Minasian, Lori; Meyskens, Frank L; Gelber, Richard D; Hortobagyi, Gabriel N; Albain, Kathy S
2016 JCO Volume 34 Issue 6 February (19).pdf.jpg2016J OURNAL OF C LINICAL O NCOLOGY Reply to A . Oguz et al No relationship to disclose No relationship to discloseHolmes, Eileen; Campbell, Christine; Bradbury, Ian; Zujewski, Jo Anne; Gelber, Richard D; Campbell, Christine; Bradbury, Ian
2016 JCO Volume 34 Issue 28 October (5).pdf.jpg2016Low-Dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor – Negative Early Breast Cancer : International Breast Cancer Study Group Trial 22-00Colleoni, Marco; Gray, Kathryn P; Gelber, Shari; Gianni, Lorenzo; Abdi, Ehtesham A; Gomez, Henry L; Linderholm, Barbro K; Puglisi, Fabio; Tondini, Carlo; Kralidis, Elena; Eniu, Alexandru; Cagossi, Katia; Rauch, Daniel; Chirgwin, Jacquie; Gelber, Richard D; Regan, Meredi
2012Prognostic interaction between expression of p53 and estrogen receptor in patients with node-negative breast cancer: results from IBCSG Trials VIII and IXCoates, Alan S; Millar, Ewan KA; O'Toole, Sandra A; Molloy, Timothy J; Viale, Giuseppe; Goldhirsch, Aron; Regan, Meredith M; Gelber, Richard D; Sun, Zhuoxin; Castiglione-Gertsch, Monica; Gusterson, Barry; Musgrove, Elizabeth A; Sutherland, Robert L
2012Prognostic interaction between expression of p53 and estrogen receptor in patients with node-negative breast cancer: results from IBCSG Trials VIII and IXCoates, Alan S; Millar, Ewan KA; O'Toole, Sandra A; Molloy, Timothy J; Viale, Giuseppe; Goldhirsch, Aron; Regan, Meredith M; Gelber, Richard D; Sun, Zhuoxin; Castiglione-Gertsch, Monica; Gusterson, Barry; Musgrove, Elizabeth A; Sutherland, Robert L
2016 JCO Volume 34 Issue 21 July (5).pdf.jpg2016Treatment Adherence and Its Impact on Disease-Free Survival in the Breast International Group 1-98 Trial of Tamoxifen and Letrozole , Alone and in SequenceChirgwin, Jacquie H; Giobbie-hurder, Anita; Coates, Alan S; Price, Karen N; Ejlertsen, Bent; Debled, Marc; Gelber, Richard D; Goldhirsch, Aron; Smith, Ian; Rabaglio, Manuela; Forbes, John F; Neven, Patrick